On a Mission to Listen to Millions of Hearts

Introducing CADScor®System — an AI-powered acoustic diagnostic aid to rule out significant coronary artery disease in 10 minutes.*

Learn more about CADScor®System

Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*

Non-invasive and radiation-free assessment for early rule-out of significant CAD.

Can help save costs of more advanced CAD diagnostics in up to 35% of patients.¹

Rapid and easy-to-use, with clear results in 10 minutes.

Rule-Out significant CAD in Just 10 Minutes with at least 96% Confidence (Negative Predictive Value)¹

CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.² In just 10 minutes, it calculates a patient-specific CAD-score, and couples it with risk factors to indicate the patient’s risk of significant coronary stenosis. CADScor®System has been used in over 24,000 patient assessments³ and has CE-marking and FDA De Novo clearance.

Learn more about CADScor®System
Physicians’ Experiences Using CADScor®System
Explore customer feedback
Schedule a Demo of CADScor®System

Schedule a free demo of CADScor®System and learn how to rule out significant CAD patients in 10 minutes.

Book a CADScor®System demo

Latest News

See all news
June 9, 2023

Announcement from Acarix's extra general meeting

May 22, 2023

Notice of Extra General Meeting in Acarix AB


Latest Press Releases

See all press

  1. User manual US-FDA v.12.Y, prevalence 10,7%
  2. Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
  3. Based on commercial patch use since 2017
*Rule-out with at least 96% confidence (NPV)